Search results for "obp"

showing 10 items of 13 documents

Identification of a lysyl residue defining the binding specificity of a human odorant-binding protein

2008

International audience

OBP[CHIM.OTHE] Chemical Sciences/OtherLYSYL RESIDUEBINDING SPECIFICITY[CHIM.OTHE]Chemical Sciences/OtherComputingMilieux_MISCELLANEOUSODORANT-BINDING PROTEIN
researchProduct

Dianthus superbus as a critically endangered species in Latvia: evaluation of its growth conditions and conservation possibilities

2021

Abstract Dianthus superbus is one of the most endangered species in Latvia and is on the verge of local extinction. Therefore, the aim of this study was to inventory previously identified populations of D. superbus in Latvia and to develop activities to conserve this species in accordance with the results obtained in situ. Expeditions on 18 previously documented locations, according to the data of Nature Conservation Agency, revealed only three existing D. superbus localities in Latvia with a significant number of specimens located in the Latgale region near Silenieki. In 2020, for the first time, two more new D. superbus localities were found in the vicinity of these three approved locatio…

AcademicSubjects/SCI01210habitat characteristics in situRange (biology)Endangered speciesDianthus superbusPlant ScienceConservation optionsBiologybiology.organism_classificationAobpla/1006HorticultureCritically endangeredAobpla/1059GerminationLocal extinctionseed viability and germinationShootStudiesBotanical gardensoil agrochemical analysisAobpla/1025AoB PLANTS
researchProduct

The Proton-Boron Reaction Increases the Radiobiological Effectiveness of Clinical Low- and High-Energy Proton Beams: Novel Experimental Evidence and …

2021

Protontherapy is a rapidly expanding radiotherapy modality where accelerated proton beams are used to precisely deliver the dose to the tumor target but is generally considered ineffective against radioresistant tumors. Proton-Boron Capture Therapy (PBCT) is a novel approach aimed at enhancing proton biological effectiveness. PBCT exploits a nuclear fusion reaction between low-energy protons and 11B atoms, i.e. p+11B→ 3α (p-B), which is supposed to produce highly-DNA damaging α-particles exclusively across the tumor-conformed Spread-Out Bragg Peak (SOBP), without harming healthy tissues in the beam entrance channel. To confirm previous work on PBCT, here we report new in-vitro data obtained…

Cancer ResearchProtonmedicine.medical_treatmentSobpBragg peakBSH030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineRadioresistancemedicineIrradiationRC254-282Original Researchprotontherapycancer cell killingChemistryalpha-particleNeoplasms. Tumors. Oncology. Including cancer and carcinogensProton-Boron ReactionRadiation therapyCell killingchromosome aberrationsOncology030220 oncology & carcinogenesisCancer researchproton-boron (B) fusion-enhanced proton therapy (PBFEPT)chromosome aberrationBeam (structure)Frontiers in Oncology
researchProduct

Structure of rat odorant-binding protein OBP1 at 1.6 angstrom resolution

2009

The nasal mucosa is a specialist interfacial region sandwiched between the olfactory system and the gaseous chemical milieu. In mammals and insects, this region is rich in odorant-binding proteins that are thought to aid olfaction by assisting mass transfer of the many different organoleptic compounds that make up the olfactory landscape. However, in mammals at least, our grasp on the exact function of odorant-binding proteins is tentative and better insight into the role of these proteins is warranted, not least because of their apparent significance in the olfactory systems of insects. Here, the crystal structure of rat odorant-binding protein 1 is reported at 1.6 Å resolution. This prote…

Models MolecularOlfactory systemCristallographyProtein ConformationRecombinant Fusion ProteinsMolecular Sequence DataOlfactionOBP1Crystallography X-RayReceptors Odorant010402 general chemistry01 natural sciencesPheromonesPichia pastoris03 medical and health sciences[ CHIM.CRIS ] Chemical Sciences/CristallographyProtein structureSpecies SpecificityStructural BiologyODORANT-BINDING PROTEINS[CHIM.CRIS]Chemical Sciences/CristallographyAnimalsAmino Acid SequencePeptide sequence030304 developmental biology0303 health sciencesBinding SitesSequence Homology Amino AcidbiologyProteinsGeneral MedicineLigand (biochemistry)biology.organism_classificationLipocalinsRatsCristallographie0104 chemical sciencesTransport proteinDNA-Binding ProteinsBiochemistryOdorant-binding proteinbiology.proteinODORANT-BINDING PROTEINS;OBP1Sequence Alignment
researchProduct

Xenopus Laevis and Xenopus Tropicalis have different number of OBP genes : Xlaeobp and Xtroobp

2008

International audience

OBPOBP GENEXENOPUS TROPICALISXENOPUS LAEVIS[CHIM.OTHE] Chemical Sciences/OtherXLAEOBPODORANT BINDING PROTEIN[CHIM.OTHE]Chemical Sciences/OtherXTROOBPComputingMilieux_MISCELLANEOUS
researchProduct

Two novel members of OBP family identified in the honeybee : sexual dimorphism and development studies

1998

International audience

OBPHONEYBEEINSECTESEXUAL DIMORPHISM[CHIM.OTHE] Chemical Sciences/OtherODORANT BINDING PROTEIN[CHIM.OTHE]Chemical Sciences/OtherComputingMilieux_MISCELLANEOUS
researchProduct

DOSIMETRIA ESR CON ALANINA PER ADRONTERAPIA CON IONI CARBONIO

2015

La sicurezza del paziente sottoposto a trattamenti terapeutici con radiazioni ionizzanti e il buon esito degli ultimi sono strettamente legati all’ottimizzazione delle procedure di esposizione alle radiazioni ionizzanti. In particolare è fondamentale arrecare il danno minore possibile ai tessuti sani che circondano la neoplasia da trattare. Rispetto ai campi di radiazione convenzionali utilizzati in radioterapia (fotoni), le particelle cariche pesanti (protoni e ioni carbonio) offrono diversi vantaggi quali la bassa dispersione laterale, l’alta efficacia biologica (RBE) nella regione del picco di Bragg ed un profilo di dose caratteristico in profondità del tutto differente da quello dei fot…

CARBON IONS ESR EPR ALANINE DOSIMETRY LEM MODEL SOBPSettore FIS/01 - Fisica SperimentaleSettore FIS/07 - Fisica Applicata(Beni Culturali Ambientali Biol.e Medicin)
researchProduct

Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study

2017

Abstract Background Familial hypercholesterolemia (FH) is an autosomal dominant disease characterized by elevated plasma levels of LDL-cholesterol that confers an increased risk of premature atherosclerotic cardiovascular disease. Early identification and treatment of FH patients can improve prognosis and reduce the burden of cardiovascular mortality. Aim of this study was to perform the mutational analysis of FH patients identified through a collaboration of 20 Lipid Clinics in Italy (LIPIGEN Study). Methods We recruited 1592 individuals with a clinical diagnosis of definite or probable FH according to the Dutch Lipid Clinic Network criteria. We performed a parallel sequencing of the major…

0301 basic medicineApolipoprotein ECandidate geneSettore MED/09 - Medicina InternaDatabases FactualApolipoprotein BDNA Mutational AnalysisFamilial hypercholesterolemia030204 cardiovascular system & hematologyCompound heterozygosityPCSK90302 clinical medicineRisk FactorsReceptorsGeneticsHomozygoteAutosomal dominant traitPathogenic variantsGeneral MedicinePrognosisAPOB; Familial hypercholesterolemia; LDLR; PCSK9; Pathogenic variantsCholesterolPhenotypeItalyAutosomal Recessive HypercholesterolemiaApolipoprotein B-100lipids (amino acids peptides and proteins)Proprotein Convertase 9APOBCardiology and Cardiovascular MedicinePreliminary DataGenetic MarkersFamilial hypercholesterolemiaLDLRPCSK9APOBPathogenic variantsHeterozygoteFamilial hypercholesterolemiaBiologyPathogenic variantLDLHyperlipoproteinemia Type II03 medical and health sciencesDatabasesmedicineInternal MedicineHumansAPOB; Familial hypercholesterolemia; LDLR; Pathogenic variants; PCSK9; Internal Medicine; Cardiology and Cardiovascular MedicineGenetic Predisposition to DiseaseFactualPCSK9Settore MED/13 - ENDOCRINOLOGIAAPOB; Familial hypercholesterolemia; LDLR; Pathogenic variants; PCSK9; Cardiology and Cardiovascular Medicine; Internal Medicinemedicine.diseaseAtherosclerosis030104 developmental biologyLDLRReceptors LDLMutationbiology.proteinAPOB; Familial hypercholesterolemia; LDLR; Pathogenic variants; PCSK9; Apolipoprotein B-100; Atherosclerosis; Cholesterol; DNA Mutational Analysis; Databases Factual; Genetic Markers; Genetic Predisposition to Disease; Heterozygote; Homozygote; Humans; Hyperlipoproteinemia Type II; Italy; Phenotype; Preliminary Data; Prognosis; Proprotein Convertase 9; Receptors LDL; Risk Factors; Mutation; Internal Medicine; Cardiology and Cardiovascular Medicine
researchProduct

De l’ingénierie de protéines de liaison aux odorants à la détection électrochimique de molécules volatiles vers la conception de biocapteurs et nez é…

2014

The detection of odorant molecules has become an important challenge in different research area, such as the food industry, medical diagnostics and homeland security. Indeed, the thousands of odorants in our environment provide information on their chemical nature or their concentration. Human olfactory system is capable of discriminating thousands of different molecules thanks to biochemical mechanisms involving multiple protein receptor partners and a combinatorial coding. These biomolecules that include olfactory receptors and odorant-binding proteins (OBP) represent an interesting source of detectors for the design of biosensors. OBPs are small soluble proteins present in nasal mucus at…

obp[SDV.AEN] Life Sciences [q-bio]/Food and Nutritionbiocapteurs[CHIM.ANAL] Chemical Sciences/Analytical chemistryelectrochemistry[CHIM.ANAL]Chemical Sciences/Analytical chemistryélectrochimiesquare-wave voltammetrysite-directed mutagenesisbiosensorsvoltammétrie à vagues carrées[SDV.AEN]Life Sciences [q-bio]/Food and Nutritionmutagenèse dirigée
researchProduct

Novel canine odorant binding proteins

2022

The present invention relates to the use of a sequence chosen among Seq ID No 3, Seq ID No l, Seq ID No 2, Seq ID No 4, Seq ID No 5, Seq ID No 6, Seq ID No 7, Seq ID No 8, and functional variants thereof, as an odorant binding protein (OBP).

OBP[SDV.AEN] Life Sciences [q-bio]/Food and NutritionOdorant binding Protein[SDV.BBM.BM] Life Sciences [q-bio]/Biochemistry Molecular Biology/Molecular biology
researchProduct